Oxidation of xenobiotics by recombinant human cytochrome P450 1B1

Drug Metabolism and Disposition

Volumn 25, Issue 5, 1997, Pages 617-622

  Shimada, Tsutomu ^a   Gillam, Elizabeth M J ^b   Sutter, Thomas R ^b   Strickland, Paul T ^b   Guengerich, F Peter ^b   Yamazaki, Hiroshi ^b  

^a OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHOXYCOUMARIN; AROMATIC NITRO COMPOUND; BENZO[A]PYRENE; BUFURALOL; CAFFEINE; CARCINOGEN; CHLORZOXAZONE; COMPLEMENTARY DNA; COUMARIN; CYTOCHROME P450; MEPHENYTOIN; NIFEDIPINE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; TESTOSTERONE; THEOPHYLLINE; TOLBUTAMIDE; XENOBIOTIC AGENT;

ARTICLE; DNA DAMAGE; DRUG OXIDATION; ENZYME SUBSTRATE; ESCHERICHIA COLI; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN FAMILY; XENOBIOTIC METABOLISM;

ANTIBODIES; ARYL HYDROCARBON HYDROXYLASES; CATALYSIS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; ESCHERICHIA COLI; HUMANS; KINETICS; MICROSOMES, LIVER; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; SUBSTRATE SPECIFICITY; XENOBIOTICS;

ESCHERICHIA COLI;

EID: 0030968797     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. D. R. Nelson, L. Koymans, T. Kamataki, J. J. Stegeman, R. Feyereisen, D. J. Waxman, M. R. Waterman, O. Gotoh, M. J. Coon, R. W. Estabrook, I. C. Gunsalus, and D. W. Nebert: P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6, 1-42 (1996).
2. F. P. Guengerich: Human cytochrome P450 enzymes. In "Cytochrome P450" (P. R. Oritiz de Montellano, ed.), pp. 473-535. Plenum Press, New York, 1995.
3. O. Pelkonen and D. W. Nebert: Metabolism of polycyclic aromatic hydrocarbons: Etiologic role in carcinogenesis. Pharmacol. Rev. 34, 189-222 (1982).
4. A. Dipple and C. A. H. Bigger: Mechanism of action of food-associated polycyclic aromatic hydrocarbon carcinogens. Mutat. Res. 259, 263-276 (1991).
5. F. P. Guengerich and T. Shimada: Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 4, 391-407 (1991).
6. F. J. Gonzalez and H. V. Gelboin: Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab. Rev. 26, 165-183 (1994).
7. T. Shimada, C. L. Hayes, H. Yamazaki, S. Amin, S. S. Hecht, F. P. Guengerich, and T. R. Sutter: Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Res. 56, 2979-2984 (1996).
8. T. R. Sutter, Y. M. Tang, C. L. Hayes, P. Wo Y-Y, W. Jabs, X. Li, H. Yin, C. W. Cody, and W. F. Greenlee: Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem. 269, 13092-13099 (1994).
9. U. Savas, K. K. Bhattacharyya, M. Christou, D. L. Alexander, and C. R. Jefcoate: Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. J. Biol. Chem. 269, 14905-14911 (1994).
10. J. Abel, W. Li, O. Dohr, C. Vogel, and S. Donat: Dose-response relationship of cytochrome P4501B1 mRNA induction by 2,3,7,8-tetrachloro-dibenzo-p-dioxin in livers of C57BL/6J and DBA/2J mice. Arch. Toxicol. 70, 510-513 (1996).
11. N. J. Walker, J. A. Gastel, L. T. Costa, G. C. Clark, G. W. Lucier, and T. R. Sutter: Rat CYP1B1: an adrenal cytochrome P450 that exhibits sex dependent expression in livers and kidneys of TCDD-treated animals. Carcinogenesis 16, 1319-1327 (1995).
12. U. Savas and C. R. Jefcoate: Dual regulation of cytochrome P450EF expression via the aryl hydrocarbon receptor and protein stabilization in C3H/10T1/2 cells. Mol. Pharmacol. 45, 1153-1159 (1994).
13. S. Otto, K. K. Bhattacharyya, and C. R. Jefcoate: Polycyclic aromatic hydrocarbon metabolism in rat adrenal, ovary, and testis microsomes is catalyzed by the same novel cytochrome P450 (P450RAP). Endocrinology 131, 3067-3076 (1992).
14. O. Dohr, C. Vogel, and J. Abel: Different response of 2,3,7,8-tetrachlo-rodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells. Arch. Biochem. Biophys. 321, 405-412 (1995).
15. C. L. Hayes, D. C. Spink, B. C. Spink, J. C. Cao, N. J. Walker, and T. R. Sutter: 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. USA 93, 9776-9781 (1996).
16. Z. Guo, E. Gillam, S. Ohmori, R. H. Tukey, and F. P. Guengerich: Expression of modified human cytochrome P450 1A1 in Escherichia coli: Effects of 5′ substitution, stabilization, purification, spectral characterization, and catalytic properties. Arch. Biochem. Biophys. 312, 436-446 (1994).
17. P. Sandhu, Z. Guo, T. Baba, M. V. Martin, R. H. Tukey, and F. P. Guengerich: Expression of modified human cytochrome P450 1A2 in Escherichia coli. Stabilization, purification, spectral characterization, and catalytic activities of the enzymes. Arch. Biochem. Biophys. 309, 168-177 (1994).
18. T. Shimada, M. Iwasaki, M. V. Martin, and F. P. Guengerich: Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA1535/pSK1002. Cancer Res. 49, 3218-3228 (1989).
19. T. Shimada, H. Yamazaki, M. Mimura, Y. Inui, and F. P. Guengerich: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270, 414-423 (1994).
20. H. Yamazaki, Z. Guo, M. Persmark, M. Mimura, K. Inoue, F. P. Guengerich, and T. Shimada: Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. Mol. Pharmacol. 46, 568-577 (1994).
21. E. M. J. Gillam, Z. Guo, M. V. Martin, C. M. Jenkins, and F. P. Guengerich: Expression of cytochrome P450 2D6 in Escherichia coli, purification, and spectral and catalytic characterization. Arch. Biochem. Biophys. 319, 540-550 (1995).
22. E. M. J. Gillam, Z. Guo, and F. P. Guengerich: Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties. Arch. Biochem. Biophys. 312, 59-66 (1994).
23. E. Gillam, T. Baba, B. R. Kim, S. Ohmori, and F. P. Guengerich: Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch. Biochem. Biophys. 305, 123-131 (1993).
24. C. H. Yun, T. Shimada, and F. P. Guengerich: Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol. Pharmacol. 40, 679-685 (1991).
25. T. Shimada, and S. Nakamura: Cytochrome P-450-mediated activation of procarcinogens and promutagens to DNA-damaging products by measuring expression of umu gene in Salmonella typhimurium TA1535/ pSK1002. Biochem. Pharmacol. 36, 1979-1987 (1987).
26. L. S. Kaminsky, M. J. Fasco, and F. P. Guengerich: Production and application of antibodies to rat liver cytochrome P-450. Methods Enzymol. 74, 262-272 (1981).
27. Y. Yasukochi and B. Masters: Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography. J. Biol. Chem. 251, 5337-5344 (1976).
28. H. Taniguchi, Y. Imai, T. Iyanagi, and R. Sato: Interaction between NADPH-cytochrome P-450 reductase and cytochrome P-450 in the membrane of phosphatidylcholine vesicles. Biochim. Biophys. Acta 550, 341-356 (1979).
29. F. P. Guengerich: Analysis and characterization of enzymes. In "Principles and Methods of Toxicology" (A. W. Hayes, ed.), pp. 1259-1313. Raven Press, New York, 1994.
30. 5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethyl-amine by recombinant cytochrome P450 2E1 and by human liver microsomes. Biochem. Pharmacol. 52, 301-309 (1996).
31. 5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Arch. Biochem. Biophys. 325, 174-182 (1996).
32. H. Yamazaki, M. Mimura, C. Sugahara, and T. Shimada: Catalytic roles of rat and human cytochrome P450 2A enzymes in testosterone 7α-and coumarin 7-hydroxylations. Biochem. Pharmacol. 48, 1524-1527 (1994).
33. J. F. Tjia, J. Colbert, and D. J. Back: Theophylline metabolism in human liver microsomes: Inhibition studies. J. Pharmacol. Exp. Ther. 276, 912-917 (1996).
34. PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. USA 86, 7696-7700 (1989).
35. T. Shimada, K. S. Misono, and F. P. Guengerich: Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J. Biol. Chem. 261, 909-921 (1986).
36. R. G. Knodell, S. D. Hall, G. R. Wilkinson, and F. P. Guengerich: Hepatic metabolism of tolbutamide: Characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition. J. Pharmacol. Exp. Ther. 241, 1112-1119 (1987).
37. T. Kronbach, D. Mathys, J. Gut, T. Catin, and U. A. Meyer: High-performance liquid chromatographic assays for bufuralol 1′-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. Anal. Biochem. 162, 24-32 (1987).
38. T. Omura and R. Sato: The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239, 2370-2378 (1964).
39. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall: Protein measurement with the Polin phenol reagent. J. Biol. Chem. 193, 265-275 (1951).
40. T. Shimada and Y. Okuda: Metabolic activation of environmental carcinogens and mutagens by human liver microsomes: role of cytochrome P-450 homologous to a 3-methylcholanthrene-inducible isozyme in rat liver. Biochem. Pharmacol. 37, 459-465 (1988).
41. T. R. Sutter, K. Guzman, K. M. Dold, and W. F. Greenlee: Targets for dioxin: Genes for plasminogen activator inhibitor-2 and interleukin-1β. Science 254, 415-418 (1995).
42. Z. Shen, J. Liu, R. L. Wells, and M. M: Elkind: cDNA cloning, sequence analysis, and induction by aryl hydrocarbons of a murine cytochrome P450 gene, CYP1B1. DNA Cell Biol. 13, 763-769 (1994).
43. K. K. Bhattacharyya, P. B. Brake, S. E. Eltom, S. A. Otto, and C. R. Jefcoate: Identification of a rat adrenal cytochrome P450 active in polycyclic hydrocarbon metabolism as rat CYP1B1. J. Biol. Chem. 270, 11595-11602 (1995).
44. S. Otto, C. Marcus, C. Pidgeon, and C. Jefcoate: A novel adrenocorticotropin-inducible cytochrome P450 from rat adrenal microsomes catalyzes polycylic aromatic hydrocarbon metabolism. Endocrinology 129, 970-982 (1991).
45. L. H. Pottenger, M. Christou, and C. R. Jefcoate: Purification and immunological characterization of a novel cytochrome P450 from C3H/ 10T1/2 cells. Arch. Biochem. Biophys. 286, 488-497 (1991).
46. S. S. Hecht, K. El-Bayoumy, A. Rivenson, and S. Amin: Potent mammary carcinogenicity in female CD rats of a fjord region diol-epoxide of benzo[c]phenanthrene compared to a bay region diol-epoxide of benzo[a]pyrene. Cancer Res. 54, 21-24 (1995).
47. A. A. Melikian, S. Amin, K. Huie, S. S. Hecht, and R. G. Harvey: Reactivity with DNA bases and mutagenicity toward Salmonella typhimurium of methylchrysene diol epoxide enantiomers. Cancer Res. 48, 1781-1787 (1995).
48. S. Amin, J. Krzeminski, A. Rivenson, C. Kurtzke, S. S. Hecht, and K. El-Bayoumy: Mammary carcinogenicity in female CD rats of fjord region diol epoxides of benzo[c]phenanthrene, benzo[g]chrysene and dibenzo[a,l]pyrene. Carcinogenesis 16, 1971-1974 (1995).
49. C. Ioannides and D. V. Parke: The cytochrome P-450 1 gene family of microsomal hemoproteins and their role in the metabolic activation of chemicals. Drug Metab. Rev. 22, 1-85 (1990).
50. T. Shimada, C. H. Yun, H. Yamazaki, J. C. Gautier, P. H. Beaune, and F. P. Guengerich: Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol. Pharmacol. 41, 856-864 (1992).
51. S. Imaoka, K. Enomoto, Y. Oda, A. Asada, M. Fujimori, T. Shimada, S. Fujita, F. P. Guengerich, and Y. Funae: Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: Comparison of those with rat hepatic cytochrome P-450s. J. Pharmacol. Exp. Ther. 255, 1385-1391 (1990).
52. R. Peter, R. Böcker, P. H. Beaune, M. Iwasaki, F. P. Guengerich, and C. S. Yang: Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450 IIE1. Chem. Res. Toxicol. 3, 566-573 (1990).
53. V. Carriere, T. Goasduff, D. Ratanasavanh, F. Morel, J. C. Gautier, P. Beaune, and F. Berthou: Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Chem. Res. Toxicol. 6, 852-857 (1993).
54. H. Yamazaki, Z. Guo, and F. P. Guengerich: Selectivity of cytochrome P450 2E1 in chlorzoxazone 6-hydroxylation. Drug Metab. Dispos. 23, 438-440 (1995).
55. M. Ingelman-Sundberg, A. -L. Hagbjork, Y. -F. Ueng, H. Yamazaki, and F. P. Guengerich: High rates of substrate hydroxylation by human cytochrome P450 3A4 in reconstituted membranous vesicles: influence of membrane charge. Biochem. Biophys. Res. Commun. 221, 318-322 (1996).